🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in France / NCT04827225
Active, not recruiting Observational

Assessment of the Mental State of Parents of Premature Children and Impact on Neurodevelopment of the Child

NCT04827225 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2020-10-26
Last updated
2026-03-04

Condition(s) studied

Parent-Child Relations

Investigational drug(s) / intervention(s)

questionnaires

questionnaires: Questionnaires (EPDS, HADS, PPQ, MIBS, etc.) will have to be completed by the parents at different stages of their child's development (38 weeks of amenorrhea, 3 months and 24 months).

Study summary

The objective of the study is to assess the psychic profile of parents of children born prematurely

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: Parents whose child meets the following criteria: * Singleton child * Child aged up to 40 weeks of amenorrhea of age corrected at the time of inclusion * Premature child as defined below: * Born at a term less than or equal to 34 weeks of amenorrhea And or * weighing 1500g or less at birth * Hospitalized in the neonatology department of the Angers University Hospital * Child included in Réseau Grandir Ensemble (RGE) in Pays de la Loire * Informed consent form signed by both parents for their participation and the collection of data from the RGE for the child Non-inclusion Criteria: * Parents not fluent in the French language, implying not being able to complete the various questionnaires * Parents including the child : * Is from a twin pregnancy or more * Has polymalformative syndrome or chromosomal abnormalities Exclusion Criteria: \- Death of the child or one of the parents during follow-up

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
CHU Angers Angers France
CHU Toulouse Toulouse France

More University Hospital, Angers trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04827225 on ClinicalTrials.gov ↗ ← All trials in France